COVID-19 mRNA Vaccines Comirnaty and Spikevax: risk of myocarditis and pericarditis
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
|
Active substance |
|
Therapeutic area (MeSH) |
COVID-19 virus infection
|
Procedure number |
EMEA/H/C/005735; EMEA/H/C/005791
|
Regulatory outcome |
Variation
|
DHPC type |
Safety signal
|
Human ATC code |
|
Dissemination date |
19/07/2021
|